EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/ CARD9 / IRF5 / NF ‐ κB pathway

Hao Chen, Sheng Xu, Bingrong Chen, Xishan Xiong iD, Jinrui Hu, Yuhong Wu, Tianrui Wang, Huishang Wang iD

Journal of Diabetes Investigation · 2026-03 · 17 (3) · 395-410

DOI: 10.1111/jdi.70222 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Investigation, online erschienen am 08.01.2026. Verfasst von Hao Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First People's Hospital of Yongkang, Yongkang, Zhejiang Province, China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Macrophages, Inflammation, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Major Science and Technology Project of Jinhua City.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammation plays an essential role in the pathogenesis of diabetic nephropathy (DN). Linderalactone (LNL), as a natural sesquiterpene lactone, has been discovered to have anti‐inflammatory activation. However, the effects of linderalactone on diabetes‐associated renal damage remain unclear.

Methods

This study investigated the effects of LNL on renal function and inflammation in diabetic mice. Renal function, collagen deposition, and fibrosis were assessed. RNA‐sequencing was performed to identify molecular pathways affected by LNL. The Dectin1‐related pathway was analyzed in kidney tissues and RAW264.7 cells. Dectin1‐deficient and Dectin1‐overexpressing models were used to confirm the mechanism of LNL.

Results

LNL improved renal function, reduced collagen deposition and fibrosis in diabetic mice without affecting blood glucose levels. RNA‐sequencing revealed that LNL primarily impacted the Dectin1 pathway. It inhibited the Dectin1/Syk/CARD9/IRF5/NF‐κB pathway, reduced macrophage and neutrophil infiltration, and suppressed inflammatory cytokine expression. Dectin1 knockdown mimicked these effects, while Dectin1 overexpression reversed them.

Conclusions

LNL alleviates DN via suppression of macrophage inflammation by mediating the Dectin1/Syk/CARD9/IRF5/NF‐κB signaling pathway, highlighting its potential as a therapeutic agent for diabetes‐associated renal injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesMacrophagesInflammationDiabetes Mellitus, ExperimentalSesquiterpenes, GuaianeAnimalsMiceNF-kappa BSignal TransductionDectin-1Lectins, C-TypeMaleCARD Signaling Adaptor ProteinsMice, Inbred C57BLRAW 264.7 Cells

Stichwörter der Autor:innen

Diabetic nephropathyInflammationLinderalactone

Substanzen

NF-kappa BDectin-1Lectins, C-TypeCARD Signaling Adaptor ProteinsSesquiterpenes, GuaianeCard9 protein, mouse

Autor:innen und Institutionen

  • Department of Nephrology, The First People's Hospital of Yongkang, Yongkang, Zhejiang Province, China.
  • Department of Traditional Chinese Medicine, The First People's Hospital of Yongkang, Yongkang, Zhejiang Province, China.

ORCID-Profile: Xishan Xiong, Huishang Wang

Förderung

  • Key Major Science and Technology Project of Jinhua City

Zitieren

APA

Chen, H., Xu, S., Chen, B., Xiong, X., Hu, J., Wu, Y., Wang, T., & Wang, H. (2026). Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/ CARD9 / IRF5 / NF ‐ κB pathway. Journal of Diabetes Investigation, 17(3), 395-410. https://doi.org/10.1111/jdi.70222

Vancouver

Chen H, Xu S, Chen B, Xiong X, Hu J, Wu Y, et al. Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/ CARD9 / IRF5 / NF ‐ κB pathway. Journal of Diabetes Investigation. 2026;17(3):395-410. doi:10.1111/jdi.70222

BibTeX
@article{Chen2026,
  author = {Chen, Hao and Xu, Sheng and Chen, Bingrong and Xiong, Xishan and Hu, Jinrui and Wu, Yuhong and Wang, Tianrui and Wang, Huishang},
  title = {Linderalactone mitigates diabetic renal injury by inhibiting macrophage inflammation via the Dectin1/Syk/ CARD9 / IRF5 / NF ‐ κB pathway},
  journal = {Journal of Diabetes Investigation},
  year = {2026},
  volume = {17},
  number = {3},
  pages = {395--410},
  doi = {10.1111/jdi.70222}
}
Kostenlos starten →